Pfizer's earnings call reflected a strong financial performance with solid revenue and EPS growth, driven by effective cost management and advancements in the R&D pipeline. However, challenges such as impacts from the IRA Medicare Part D redesign and ongoing geopolitical uncertainties pose potential risks.

Company Guidance

During Pfizer's Second Quarter 2025 Earnings Conference Call, the company provided updated guidance reflecting strong year-to-date performance. Specifically, Pfizer raised its adjusted diluted EPS guidance for the full year 2025, driven by productivity gains and strategic initiatives to expand margins. The company reported second-quarter revenues of $14.7 billion, a 10% operational increase, and adjusted diluted EPS of $0.78, surpassing expectations. Pfizer's robust operating margins were achieved amidst challenges such as an $825 million unfavorable impact from higher manufacturer discounts due to the IRA Medicare Part D redesign. Pfizer's non-COVID portfolio, including strong performers like the Vyndaqel family and Eliquis, contributed significantly to its solid financial outlook. The company maintained its full-year 2025 revenue guidance of $61 billion to $64 billion and adjusted its SI&A and R&D expense forecasts while expecting an adjusted effective tax rate of approximately 13%. Pfizer's strategic focus remains on enhancing R&D productivity, leveraging AI and digital capabilities, and optimizing capital allocation to create long-term shareholder value.

Strong Revenue Growth

Pfizer recorded revenues of $14.7 billion for the second quarter, representing a 10% operational increase year-over-year.

Increased Earnings Guidance

Pfizer raised its adjusted diluted EPS guidance for the full year 2025 by $0.10, indicating strong performance and confidence in future results.

R&D Pipeline Advancements

Significant progress in the R&D pipeline with promising data for Elrexfio, SV, and Hympavzi, as well as the development of a C. diff vaccine.

Cost Management Success

Total adjusted operating expenses decreased by 8% operationally, demonstrating effective cost management strategies.

Strong Performance of Key Products

Products like Vyndaqel, Eliquis, and Padcev showed significant growth, with Vyndaqel growing 21% year-over-year operationally.

PFIZER LIMITED (IN:PFIZER) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

IN:PFIZER Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 27, 2025	2026 (Q2)	42.90 / -	34.6	―	―	―
Aug 13, 2025	2026 (Q1)	34.70 / 41.90	32.9	27.36% (+9.00)	―	―
May 19, 2025	2025 (Q4)	35.85 / 43.00	39.1	9.97% (+3.90)	―	―
Jan 31, 2025	2025 (Q3)	31.80 / 27.90	27.1	2.95% (+0.80)	―	―
Oct 28, 2024	2025 (Q2)	37.00 / 34.60	32.6	6.13% (+2.00)	―	―
Jul 29, 2024	2025 (Q1)	- / 32.90	20.45	60.88% (+12.45)	―	―
May 29, 2024	2024 (Q4)	34.70 / 39.10	31.7	23.34% (+7.40)	―	―
Feb 09, 2024	2024 (Q3)	32.80 / 27.10	32.9	-17.63% (-5.80)	―	―
Oct 28, 2023	2024 (Q2)	- / 32.60	37.1	-12.13% (-4.50)	―	―
Aug 11, 2023	2024 (Q1)	- / 20.45	29.5	-30.68% (-9.05)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

IN:PFIZER Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 13, 2025	₹5087.05	₹5125.80	+0.76%
May 19, 2025	₹4286.96	₹4338.36	+1.20%
Jan 31, 2025	₹4389.19	₹4408.14	+0.43%
Oct 28, 2024	₹5159.00	₹5128.63	-0.59%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does PFIZER LIMITED (IN:PFIZER) report earnings?

PFIZER LIMITED (IN:PFIZER) is schdueled to report earning on Oct 27, 2025, TBA (Confirmed).

What is PFIZER LIMITED (IN:PFIZER) earnings time?

PFIZER LIMITED (IN:PFIZER) earnings time is at Oct 27, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of PFIZER LIMITED stock?

The P/E ratio of PFIZER LIMITED is N/A.

What is IN:PFIZER EPS forecast?

IN:PFIZER EPS forecast for the fiscal quarter 2026 (Q2) is 42.9.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing